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The Issue of Childhood Cancer
• Cancer is the number one cause of
death by disease for children
•
•

Approximately 12,000 children were
diagnosed in 2012
5-year survival rate is 83%

• Quality of life for the entire family
remains a concern
• Evidence-based interventions to help
the family during this experience are
needed
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Why the Canines and Childhood Cancer (CCC) Study?
•

Animal-assisted therapy (AAT) is a
promising intervention to help families
dealing with childhood cancer

•

Studies regarding human-animal
interactions date back to the late 1970’s
• Primarily anecdotal
• Lack scientific rigor

•

As a result, AAT has received:
• Limited recognition by medical
professionals
• Limited support from government
funding agencies
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CCC Study Features

• Randomized control cohort
• Multi-site
• Large sample size
• Validated measurement instruments
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American Humane Association
•

The country’s first national humane
organization

•

The only charity dedicated to the
protection of both children and animals

•

Mission since 1877:
•
•

Ensure the welfare, wellness and wellbeing of children and animals
Unleash the full potential of the bond
between humans and animals to the
mutual benefit of both
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Zoetis
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•

Formerly the animal health
business of Pfizer

•

Working to ensure a safe,
sustainable global food supply

•

Helping dogs, cats and horses
live healthier and longer lives

Our Study Approach
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CCC Study Plan
Stage I

Stage III

•

Comprehensive Literature Review and
Focus Groups/Interviews

• Finalize Full Trial Study Design

•

Pilot Study Design

• IRB/IACUC Full Trial Processes

•

Site Recruitment/IRB and IACUC

• Conduct Full Clinical Trial

Stage II
•

Conduct Pilot Study

•

Data Analyses & Report Generation
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Literature Review
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•

Published in January 2012

•

Intended to serve as a study background and a resource to
the pediatric oncology and human-animal interaction fields

•

Covers more than 150 literature sources

•

Reviewed by experts in pediatric medicine, animal welfare
and behavior, and human-animal interaction

•

Available at: www.caninesandchildhoodcancer.org

Focus Group and Interview Process
• Focus groups and interviews were conducted
with three sites to inform study design and
planning:
•

East Tennessee Children’s Hospital in
Knoxville, TN
• University of TN College of Veterinary
Medicine

•

Monroe Carell Jr. Children’s Hospital at
Vanderbilt in Nashville, TN

•

St. Joseph’s Children’s Hospital in
Tampa, FL
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Summary of Findings from Literature Review,
Focus Groups, and Interviews
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Brief Overview of Pediatric Oncology
• Over the past 2 decades, while the incidence of
cancer has increased slightly, the mortality rates
from cancer have drastically decreased
• Leukemia is the most common form of all
childhood cancers
• Most prevalent in children under the age of 10
years, peaked around age 3-4 years
• Treatment is approximately 2 years for females
and 3 years for males
• Nearly 2,500 new cases are diagnosed in the U.S.
every year
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Effects of Cancer Treatment on Children
•
•
•
•
•
•
•
•
•
•
•
•
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Distress and anxiety
Anger
Body image, self-esteem, and identity issues
Depression
Academic performance
Fear of infection, relapse, or death
Immunosuppression
Mood and behavior swings due to steroids
Pain and discomfort
Social isolation
Worry about family wellbeing
Improved social functioning and confidence

Effects of Childhood Cancer on Families
•
•
•
•
•
•
•
•
•
•
•

Distress and anxiety
Depression and grief
Fear of infection, relapse, and death
Guilt
Post traumatic stress symptoms
Financial and employment concerns
Social isolation and loneliness
Strain on relationships
Hard on siblings
Increased family closeness
Weight gain and decreased physical activity
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Benefits of Animal-Assisted Therapy
• Reduced stress and anxiety
• Distraction from pain and worry
• Decreased heart rate and blood
pressure
• Help with coping
• Mood elevation
• Decrease loneliness
• Facilitate rapport and social
interaction between people
• Normalize the hospital experience
• Motivate active participation in the
treatment process
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Safely Implementing AAT in Hospitals
•

Human safety and well-being
•

Risk management and infection control policies
and procedures

•

Therapy dog safety and well-being

•

Animal-handler team training and
certification

•

Setting and participant selection
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Typical Therapy Dog Visit in Pediatric Oncology
•
•
•
•
•
•

•
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Handlers and their dogs visit from room
to room and in common areas
Interact with both patients and families
Handlers and dogs typically visit once a
week
Length of time with each child and family
varies
Handler’s role is to advocate for their dog
Typical conversation is around the dog’s
characteristics and about the family’s pets
Activities may include petting, brushing,
and giving the dog commands

Current State of AAT Research
• Rigorous and evidence-based research in the field of AAT continues to be lacking

• Much of our understanding of AAT effectiveness is based on anecdotal information
• Issues with developing and conducting AAT research include:
•
•
•
•
•
•

Gaining access to clinical settings
Timely IRB and IACUC approval
Recruiting large study samples
Multiple settings
Employing appropriate study instrumentation
Lack of standardized AAT protocols

• Lack of research on the effects of AAT on therapy dogs
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Pilot Study Design
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Designing a Study to Address the Main Findings
Main Findings

Study Design

•

Pediatric cancer patients and parents
experience substantial distress

•

Distress as the target for the AAT protocol

•

Acute lymphoblastic leukemia (ALL) is the
most common form of childhood cancer

•

Population identified as ALL patients

•

Very little rigorous research to
quantitatively measure the efficacy of AAT

•

Study design based on standard clinical
efficacy studies

•

Very little research addressing the impact
of sessions on therapy animals

•

Measure impact on the therapy dogs to
inform standards of practice
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Hypotheses
Children: Pediatric Acute Lymphoblastic Leukemia (ALL)

H1: Pediatric cancer patients with ALL who receive AAT will
experience less distress throughout the course of their
treatment sessions than patients who do not receive AAT.
Parents/Primary Caregivers

H2: Parents/primary caregivers of pediatric cancer patients
with ALL who receive AAT will experience less distress
throughout the course of their child’s treatment sessions
than parents of patients who do not receive AAT.
Therapy Dogs

H3: Participating therapy dogs will exhibit minimal distress
over the course of the CCC study.
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Study Design Overview
•

•

Randomized controlled clinical study
•

Control cohort receives standard-of-care

•

Study cohort receives standard-of-care plus AAT

Multi-site
•

•

Relatively large sample size
•

•

Staggered start dates

Goal is at least 100 participants

Validated psychosocial and biological
instrumentation
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Piloting the Study Design
• Address the feasibility of conducting a
randomized control trial utilizing AAT
within a pediatric healthcare setting
• Determine how to address issues of
scientific integrity and protocol fidelity
• Develop recommendations for revisions to
the protocol leading up to a final research
design for a full clinical trial
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Sites
• East Tennessee Children’s Hospital in
Knoxville, TN
• In conjunction with University of TN
College of Veterinary Medicine

• Monroe Carell Jr. Children’s Hospital
at Vanderbilt in Nashville, TN
• St. Joseph’s Children’s Hospital in
Tampa, FL
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Overview of Study Implementation Steps
• Identify child and determine eligibility

• Approach family and perform consent
process
• Receive group assignment and identifier
• Determine session schedule
• Match child to dog (if in treatment cohort)
• Inform family
• First session occurs
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AAT Protocol for the Pilot
•

Participating child in the treatment group is matched
with an animal-handler team

•

Visits occur approximately once a week when they come
in for their treatment

•

Interaction with therapy team is 20 minutes, +/- 10
minutes

•

Full data collection occurs weekly during the child’s
induction treatment phase, then once every two months

•

Activities during session with the therapy dog are what
typically occurs during a visit, but are documented for
tracking purposes
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Patient Instrumentation
Observational Scale of Behavioral Distress
•

Video observation and coding by American
Humane Association

Blood Pressure
•
•
•
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Blood pressure taken prior to the dog
entering the treatment session
Then again just prior to the dog exiting the
treatment session
Similar timing for control patients

Patient Instrumentation
Heart Rate Variability
•

A Polar Heart Rate Monitor is used
during the scheduled sessions

•

The child wears the chest strap

•

The watch and chest strap are removed
when the dog leaves the session

•

Similar process for control patients
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Parent Instrumentation

Demographic Sheet
•

Collected at the time of, or shortly
after, randomization and ID
assignment

Heart Rate Variability
•
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Same process as with the child

Parent Instrumentation
Pediatric Inventory for Parents
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•

Administered at any time during or immediately after
the session

•

Contains a list of 42 difficult events which parents of
children who have a serious illness sometimes face

•

Parents circle HOW OFTEN the event has occurred for
them in the past 7 days and rate how DIFFICULT the
event was/is for them

Parent Instrumentation
State Trait Anxiety Inventory
•

Administered at any time during or
immediately after the session

•

Contains 20 statements for the
caregiver to indicate how they are
feeling at that moment on a scale
from “Not At All” to “Very Much So”
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Handler Instrumentation
Demographic Sheet
•

Includes dog’s age, breed, years of
experience

Self-Reports
•
•
•
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Completed at the conclusion of each
session
Handler indicates their perception of
their dog’s stress level
Note what activities took place and
duration of the session

Therapy Dog Instrumentation
Saliva
•
•
•
•

Salivary cortisol used as a measure of stress
response
Saliva collected 20 minutes after the session
begins
Compared to a baseline measure
Shipped to Salimetrics for analysis

Ethogram
•

Video observation and coding of the dog’s
behavior by American Humane Association

www.americanhumane.org

Next Steps for the Study
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•

Continue collecting pilot data through the
end of June 2013

•

Analyze pilot study data and generate
report

•

Recruit 5 or more full clinical trial sites

•

Optimize instrumentation and protocol

•

Complete IRB and IACUC processes

•

Launch full trial in late 2013
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